你好可以帮我总结一段话吗？The past decade has seen a surge of interest in ‘born global’ firms whichinternationalise rapidly following their inception While born global internationalisationpaths are commonly associ

In the past decade, there has been a growing interest in born global firms that rapidly internationalize from their inception. Although this internationalization model is commonly associated with high-tech firms, limited research suggests that biotech ventures do not fit this model. Therefore, the aim of this research was to investigate whether biotech firms follow the born global model, and to explore how the internationalization of small biotech firms with radical innovations can be best explained. This was achieved through a comparative case study of four Australian biotech companies, with their internationalization histories forming the focal unit of analysis